Markets.News
PFIZER AND PARTNER BIONTECH SAY THEY WILL STOP U.S. COVID-19 VACCINE STUDY IN HEALTHY ADULTS AGES 50 TO 64 DUE TO SLOW ENROLLMENT - REPORTS